PL1753440T3 - Forma do podawania doustnego zawierająca bakterie probiotyczne - Google Patents

Forma do podawania doustnego zawierająca bakterie probiotyczne

Info

Publication number
PL1753440T3
PL1753440T3 PL05746643T PL05746643T PL1753440T3 PL 1753440 T3 PL1753440 T3 PL 1753440T3 PL 05746643 T PL05746643 T PL 05746643T PL 05746643 T PL05746643 T PL 05746643T PL 1753440 T3 PL1753440 T3 PL 1753440T3
Authority
PL
Poland
Prior art keywords
probiotic bacteria
administration containing
oral form
containing probiotic
oral
Prior art date
Application number
PL05746643T
Other languages
English (en)
Inventor
Markus Rudolph
Stefan Henke
Iris Manneck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34980007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1753440(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL1753440T3 publication Critical patent/PL1753440T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL05746643T 2004-05-28 2005-05-04 Forma do podawania doustnego zawierająca bakterie probiotyczne PL1753440T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004026706A DE102004026706A1 (de) 2004-05-28 2004-05-28 Orale Darreichungsform enthaltend probiotische Bakterien
EP05746643A EP1753440B1 (de) 2004-05-28 2005-05-04 Orale darreichungsform enthaltend probiotische bakterien
PCT/EP2005/004835 WO2005117921A1 (de) 2004-05-28 2005-05-04 Orale darreichungsform enthaltend probiotische bakterien

Publications (1)

Publication Number Publication Date
PL1753440T3 true PL1753440T3 (pl) 2008-05-30

Family

ID=34980007

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05746643T PL1753440T3 (pl) 2004-05-28 2005-05-04 Forma do podawania doustnego zawierająca bakterie probiotyczne

Country Status (20)

Country Link
US (2) US20090162322A1 (pl)
EP (1) EP1753440B1 (pl)
JP (1) JP5070043B2 (pl)
KR (1) KR101289413B1 (pl)
CN (1) CN1956724B (pl)
AT (1) ATE386534T1 (pl)
AU (1) AU2005249187B2 (pl)
BR (1) BRPI0511615B8 (pl)
CA (1) CA2568171C (pl)
CY (1) CY1107399T1 (pl)
DE (2) DE102004026706A1 (pl)
DK (1) DK1753440T3 (pl)
ES (1) ES2299034T3 (pl)
MX (1) MXPA06013686A (pl)
PL (1) PL1753440T3 (pl)
PT (1) PT1753440E (pl)
RU (1) RU2376023C2 (pl)
SI (1) SI1753440T1 (pl)
WO (1) WO2005117921A1 (pl)
ZA (1) ZA200610768B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5576606B2 (ja) 2005-05-18 2014-08-20 ディーエスエム アイピー アセッツ ビー．ブイ． 微生物の腸内投与用組成物
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
WO2008042101A2 (en) * 2006-10-02 2008-04-10 Danisco A/S Probiotics for use in reducing the incidence and duration of illness
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
BR112012003239B1 (pt) 2009-08-14 2021-03-16 DuPont Nutrition BioScience ApS microrganismos desidratados revestidos com estabilidade e viabilidade melhoradas
BR112012023042A2 (pt) 2010-03-12 2016-05-17 Calpis Co Ltd agente para aumentar as bifidobactérias e reduzir a diminuição das bifidobactérias no intestino grosso
CA2831345C (en) 2011-05-06 2022-05-03 Organobalance Medical Ag Lactic acid bacterial strains that coaggregate with staphylococcus aureus, and compositions and uses of the strains
KR101918792B1 (ko) 2011-05-16 2018-11-14 오르가노발란스 메디컬 아게 박테리아성 감기에 대한 신규 락트산 박테리아 및 그를 함유하는 조성물
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
US10588857B2 (en) 2012-03-29 2020-03-17 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
RU2491079C1 (ru) * 2012-07-13 2013-08-27 Федеральное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Комплексный пробиотический препарат и способ его получения
TWI481409B (zh) * 2013-01-10 2015-04-21 Conmed Pharmaceutical & Bio Medical Corp 一種使用益生菌製備用於清除尿毒素之組合物的用途
BR112015023124A2 (pt) 2013-03-14 2017-07-18 Therabiome Llc liberação de organismos probióticos e/ou agentes terapêuticos almejada para o trato gastrintestinal
US10849940B2 (en) * 2013-06-10 2020-12-01 Brock M. Lundberg Prebiotics of highly refined cellulose
KR101470995B1 (ko) * 2013-08-30 2014-12-09 주식회사 바이오리쏘스 프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물
CN106535909A (zh) 2014-07-01 2017-03-22 普罗比美国公司 双层双重释放益生菌片剂
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
US10339273B2 (en) 2015-11-18 2019-07-02 Warsaw Orthopedic, Inc. Systems and methods for pre-operative procedure determination and outcome predicting
CN111870617B (zh) * 2019-11-04 2022-06-10 深圳碳云智能数字生命健康管理有限公司 肠道益生菌补剂配方的确定方法、装置、存储介质及处理器
CN111110703B (zh) * 2020-01-13 2020-12-01 华中农业大学 动物双歧杆菌及其制备的复合菌制剂在制备治疗或预防禽流感病毒感染的药物中的应用
CN114917259B (zh) * 2022-02-15 2023-10-13 中国科学院上海硅酸盐研究所 一种二维氢硅烯-微生物复合材料及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58157726A (ja) * 1982-03-11 1983-09-19 Shin Etsu Chem Co Ltd 固形薬剤用腸溶性コ−テイング剤組成物
JPH024016A (ja) * 1988-06-20 1990-01-09 Fujitsu Ltd 半導体集積回路
JPH0441434A (ja) * 1990-06-07 1992-02-12 Asahi Breweries Ltd 腸溶性コーティングを施した乳酸菌錠剤
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IT1265092B1 (it) * 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US6168806B1 (en) * 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
CN1156271C (zh) * 2000-04-29 2004-07-07 中国科学技术大学 一种固体药剂用高分子包衣粉及其制备方法
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US20020160048A1 (en) * 2001-02-15 2002-10-31 Karoline Bechtold-Peters Medical formulation containing a muscarinic agonist
CA2439078C (en) * 2001-03-09 2009-08-25 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation

Also Published As

Publication number Publication date
EP1753440B1 (de) 2008-02-20
RU2006145056A (ru) 2008-07-10
CY1107399T1 (el) 2012-12-19
ES2299034T3 (es) 2008-05-16
ATE386534T1 (de) 2008-03-15
BRPI0511615B1 (pt) 2018-01-23
DK1753440T3 (da) 2008-06-02
PT1753440E (pt) 2008-05-28
ZA200610768B (en) 2008-07-30
CA2568171A1 (en) 2005-12-15
MXPA06013686A (es) 2007-02-13
KR20070024539A (ko) 2007-03-02
BRPI0511615A (pt) 2008-01-02
DE102004026706A1 (de) 2005-12-15
US20190110997A1 (en) 2019-04-18
WO2005117921A1 (de) 2005-12-15
DE502005002929D1 (de) 2008-04-03
BRPI0511615B8 (pt) 2021-05-25
AU2005249187B2 (en) 2011-03-17
US20090162322A1 (en) 2009-06-25
CN1956724A (zh) 2007-05-02
AU2005249187A1 (en) 2005-12-15
EP1753440A1 (de) 2007-02-21
JP5070043B2 (ja) 2012-11-07
JP2008500294A (ja) 2008-01-10
RU2376023C2 (ru) 2009-12-20
SI1753440T1 (sl) 2008-08-31
CA2568171C (en) 2013-09-17
CN1956724B (zh) 2013-08-28
KR101289413B1 (ko) 2013-08-07

Similar Documents

Publication Publication Date Title
PL1753440T3 (pl) Forma do podawania doustnego zawierająca bakterie probiotyczne
UA97502C2 (ru) Кристаллическая твердая основа разагилина
EP1919302B8 (en) Food comprising silicon
LUC00065I2 (pl)
TW200700009A (en) Active compound combinations having insecticidal and acaricidal properties
PL1663168T3 (pl) Preparaty nikotyny i ich zastosowanie
JO3324B1 (ar) مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
EP1859022A4 (en) NEW SAFETY TOLERANT LACTOBACILLUS SAKEI PROBIO-65 WITH THE CAPACITY TO SUPPORT GROWTH-BASED MICRO-ORGANISMS AND ANTI-ALLERGIC EFFECTS
TW200732349A (en) Anti-OX40L antibodies and methods using same
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
PL2169050T3 (pl) Sposób wytwarzania niealergizujących hodowli bakterii probiotycznych i ich zastosowanie
MX2007005202A (es) Polisacaridos de estreptococo modificados y usos de los mismos.
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
ATE407215T1 (de) Enzymatische demethylierung von flavonoiden
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MY148276A (en) Long-term feed- elderly
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
WO2010036344A3 (en) Compositions, oral care products and methods of making and using the same
TW200613604A (en) Preparation of fabrics having lotus leaf effect and fabrics having lotus leaf effect
SG151171A1 (en) Association between an anti-atherothrombotic and an angiotensin- converting enzyme inhibitor
PL1687014T3 (pl) Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi
GEP20084546B (en) Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent
NZ587553A (en) A new class of chloroflexi-iike thermophilic cellulose degrading bacteria
AU319802S (en) Plenum spacer 1
AU316107S (en) Blower pulleys